Previous studies have shown that elevated CHAF1B levels are closely associated with poor prognosis in patients with many different types of cancer, such as melanoma [39], prostate cancer [40], salivary gland tumors [41], nasopharyngeal carcinoma [42], and high‐grade glioma [43, 44]. Here, CHAF1B is linked to central nervous system cancer.